What Is Off-Label Use?

The Definition of Off-Label UseOff-Label Use

The use of a drug for a purpose, population, or dosage not included in its FDA-approved labeling. Off-label prescribing is legal and common — an estimated 20% of all prescriptions are off-label — but

When the FDA approves a drug, it approves it for a specific indication (medical condition), population (age group), dose, and route of administration. The drug's official label — the package insert — documents all of these approved parameters.

Off-label use means a physician prescribes an FDA-approved drug outside of these official parameters. This can mean:

• Using a drug for a different condition than it was approved for (e.g., prescribing an antiepileptic drug for chronic pain)
• Prescribing it for a different age group (e.g., using an adult drug in a child)
• Using a different dose than approved
• Administering it by a different route (e.g., crushing a tablet that is meant to be swallowed and administering it through a feeding tube)

Off-label use does not mean experimental, dangerous, or unapproved in any absolute sense — it means the FDA specifically reviewed the drug for a narrower set of uses than the ways it may be prescribed in practice.

Why Does Off-Label Use Exist?

The FDA approval process is specific and evidence-based. Obtaining approval for a new indication requires a company to fund additional clinical trials — a process that can cost hundreds of millions of dollars and take many years. Once a drug's patent expires, generic manufacturers have no financial incentive to fund those trials, even if strong real-world evidence has emerged for new uses.

As a result, clinical knowledge often outpaces the official label. Medical literature accumulates evidence for uses that were never part of the original approval application. Physicians, guided by clinical studies, guidelines from medical societies, and their own experience, begin prescribing based on that evidence — regardless of whether the FDA label has been formally updated.

Additionally, the FDA explicitly cannot regulate the practice of medicine. Once a drug is approved and on the market, physicians have the legal authority to prescribe it as they judge appropriate for their patients.

Is Off-Label Use Legal?

Yes — off-label prescribing by licensed physicians is entirely legal in the United States. The FDA regulates drug manufacturers, not prescribers.

What is not legal is for manufacturers to market or promote a drug for off-label uses. Pharmaceutical companies may only advertise and detail their products for FDA-approved indications. Violations of this rule have resulted in billions of dollars in settlements over the years.

However, companies may provide scientific and medical information about off-label uses in response to unsolicited physician requests, and medical education, journal publications, and conference presentations are all channels through which off-label evidence spreads.

How Common Is It?

Off-label prescribing is far more common than most patients realize. Studies have estimated that approximately 21% of all prescriptions in the United States are for off-label uses. In some specialties, the rate is even higher:

• Oncology: 33–60% of cancer drugs may be used off-label, because cancer subtypes and combinations are too numerous for each to receive its own trial.
• Pediatrics: Many drugs have never been formally tested in children, so pediatricians routinely prescribe adult drugs off-label with dose adjustments.
• Psychiatry: Medications for mood disorders, ADHD, and anxiety frequently find secondary uses (e.g., low-dose quetiapine for insomnia).
• Neurology: Anticonvulsants are routinely used for migraine prevention, nerve pain, and mood stabilization.

Well-Known Examples

Some of the most celebrated and effective uses of prescription drugs are off-label:

• Gabapentin (Neurontin): FDA-approved for epilepsy and postherpetic neuralgia. Widely prescribed off-label for diabetic neuropathy, fibromyalgia, anxiety, and alcohol withdrawal.
• Amitriptyline: An antidepressant rarely used at full antidepressant doses today, but extensively prescribed at low doses (10–50 mg) for insomnia, chronic pain, and migraine prevention.
• Metformin: FDA-approved for Type 2 diabetes, but prescribed off-label for polycystic ovary syndrome (PCOS) — a use supported by substantial clinical evidence.
• Propranolol: FDA-approved for hypertension and certain cardiac conditions. Used off-label for performance anxiety, stage fright, and infantile hemangiomas.
• Minoxidil: Originally approved as an oral hypertension drug. The topical form (Rogaine) was the first approved hair loss treatment, but oral minoxidil is now widely prescribed off-label for hair loss as well.

The Risks of Off-Label Prescribing

Off-label use carries a distinct risk profile compared to on-label use:

• Less evidence: The drug may not have been tested in large, rigorous trials for the condition you're being treated for. The evidence base might be small case series, observational studies, or physician experience — not the Phase III randomized controlled trials required for FDA approval.
• Dosing uncertainty: The optimal dose for an off-label use may not be well established.
• Unknown interactions in the target population: A drug tested only in adults may behave differently in children due to developmental differences in metabolism.
• Insurance coverage issues: Payers may refuse to cover off-label uses, leaving patients with unexpected out-of-pocket costs. (Some states require coverage for certain off-label oncology uses.)

When Off-Label Is Well-Supported vs. Experimental

The key question is not "Is this off-label?" but "How strong is the evidence for this use?"

Well-supported off-label use: The use appears in major clinical practice guidelines from medical organizations (e.g., the American Heart Association, American Academy of Pediatrics), is supported by multiple high-quality studies, and is standard practice among specialists. Example: using aspirin for secondary prevention of heart attack — an off-label use for many years before explicit labeling caught up with practice.

Experimental or poorly supported off-label use: The use is based on limited case reports, anecdote, or a single small trial. The risk-benefit calculation is genuinely uncertain. This is not necessarily wrong — for a patient with no other options, an experimental approach may be justified — but it requires informed consent and careful monitoring.

What to Ask Your Doctor

If you are prescribed a drug for an off-label use:

1. "Is this an approved use, or off-label?" Simply knowing allows you to ask better follow-up questions.
2. "What evidence supports this use?" Is it in treatment guidelines? Have clinical trials been conducted?
3. "Are there FDA-approved alternatives?" Sometimes an on-label drug exists but has drawbacks the prescriber is trying to avoid.
4. "Will my insurance cover this?" Check before filling the prescription.
5. "What should I watch for?" Off-label use sometimes involves less well-characterized side effect profiles.

Key Takeaways

• Off-label prescribing means using an approved drug outside the specific uses the FDA reviewed and approved.
• It is legal and common — roughly 1 in 5 prescriptions in the U.S. is off-label.
• It is not inherently dangerous, but the evidence base is typically less robust than for approved indications.
• Manufacturers cannot promote off-label uses, but physicians can prescribe them.
• Patients have a right to know when a drug is being prescribed off-label and to understand the evidence supporting that use.

This guide is for educational purposes only. It does not replace professional medical advice. Always consult your healthcare provider before making changes to your medication regimen.